Trial Profile
A Phase I, Open-Label, Single and Multiple Dose Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jun 2020
Price :
$35
*
At a glance
- Drugs Isavuconazole (Primary) ; Isavuconazole (Primary)
- Indications Aspergillosis; Candidiasis; Zygomycosis
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 26 Sep 2014 New trial record